Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 93.80% | 26.02% | 39.80% | 31.69% | 12.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.80% | 26.02% | 39.80% | 31.69% | 12.93% |
| Cost of Revenue | 35.56% | 4.31% | 5.48% | 1.82% | 2.38% |
| Gross Profit | 311.02% | 150.48% | 2,104.01% | 7,176.89% | 83.40% |
| SG&A Expenses | 62.36% | 37.00% | 27.84% | 58.66% | 80.33% |
| Depreciation & Amortization | 7.85% | 13.56% | 15.11% | 20.75% | 33.96% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.48% | 8.88% | 8.78% | 8.46% | 11.20% |
| Operating Income | 10,762.45% | 347.46% | 140.86% | 111.53% | 71.79% |
| Income Before Tax | 326.33% | -10.91% | 92.98% | 90.98% | 88.44% |
| Income Tax Expenses | 385.70% | 1,189.41% | 75.70% | -131.38% | -138.71% |
| Earnings from Continuing Operations | 319.40% | -22.90% | 93.31% | 92.02% | 89.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1,723.73% | -242.18% | -188.36% | -130.18% | -129.69% |
| Net Income | 213.96% | -42.23% | 91.30% | 90.92% | 89.22% |
| EBIT | 10,762.45% | 347.46% | 140.86% | 111.53% | 71.79% |
| EBITDA | 861.20% | 939.75% | 207.26% | 181.48% | 176.26% |
| EPS Basic | 192.80% | -50.40% | 91.12% | 90.74% | 88.96% |
| Normalized Basic EPS | 283.23% | 77.73% | 77.54% | 38.31% | -1,804.42% |
| EPS Diluted | 185.76% | -44.65% | 91.11% | 90.73% | 88.97% |
| Normalized Diluted EPS | 272.40% | 77.73% | 77.54% | 38.31% | -1,804.42% |
| Average Basic Shares Outstanding | 15.94% | 5.91% | 2.80% | -0.12% | -0.82% |
| Average Diluted Shares Outstanding | 17.86% | 5.91% | 2.80% | -0.12% | -0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 1.16% | 0.87% | -1.06% | -0.09% | 0.48% |